Literature DB >> 7587219

Physical and laboratory measurements in the PEPI Trial Postmenopausal Estrogen/Progestin Interventions.

P D Wood1, G Kessler, K Lippel, M L Stefanick, C H Wasilauskas, H B Wells.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 7587219     DOI： 10.1016/0197-2456(95)96882-c

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN： 0197-2456


× No keyword cloud information.
  4 in total

1.  Predictors of breast discomfort among women initiating menopausal hormone therapy.

Authors:  Carolyn J Crandall; Daniela Markovic; Mei-Hua Huang; Gail A Greendale
Journal:  Menopause       Date:  2010 May-Jun       Impact factor: 2.953

Review 2.  Hormone therapy in postmenopausal women and risk of endometrial hyperplasia.

Authors:  Susan Furness; Helen Roberts; Jane Marjoribanks; Anne Lethaby
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

3.  Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy.

Authors:  Carolyn J Crandall; Min Guan; Gail A Laughlin; Giske A Ursin; Frank Z Stanczyk; Sue A Ingles; Elizabeth Barrett-Connor; Gail A Greendale
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

4.  Positive association between mammographic breast density and bone mineral density in the Postmenopausal Estrogen/Progestin Interventions Study.

Authors:  Carolyn Crandall; Shana Palla; Beth A Reboussin; Giske Ursin; Gail A Greendale
Journal:  Breast Cancer Res       Date:  2005-09-22       Impact factor: 6.466
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.